Biogazelle has Established a Quality Management System
News Feb 03, 2015
Biogazelle is a Ghent University spin-off company founded in 2007 by prof. Jo Vandesompele and dr. Jan Hellemans. With a proven track record in gene expression studies, Biogazelle is at the forefront of transcriptome analyses using laboratory methods, including RNA sequencing and RT-qPCR.
Driven by science and the eager to learn from and to teach to the research community, Biogazelle has contributed to the standardization, characterization and optimization of gene expression methods resulting in numerous peer reviewed publications, cited more than 10 000 times collectively.
“For Biogazelle, scientific quality and integrity are extremely important. Therefore, we want to guarantee the quality of the work we do as a transcriptome service provider.” says Jan Hellemans, Biogazelle’s CEO.
Mathias Van Holm, quality manager at Biogazelle, adds: “Biogazelle aims to consistently deliver technically valid results, in time, by offering services tailored to the customer’s needs. Both customer satisfaction and excellence in science and technology are core values in our organization. We continuously look to improve on this level.”
In order to give the customer an independent, formal confirmation of the in-house available technical competence and the reliability of the test results, Biogazelle has established a quality management system based on the recognized international standard ISO/IEC 17025:2005.
As of today, Biogazelle is ISO 17025 accredited for different messenger RNA, microRNA and long non-coding RNA expression analyses and supporting services using RT-qPCR and RNA sequencing technologies.
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE
AIDS Vaccine Design: New Data Offers Important InsightNews
New data published in Immunity further illuminate how some human beings generate powerful, HIV-blocking antibodies. The results offer important insight into a potential AIDS vaccine design.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018